Human epididymis protein 4 reference limits and natural variation in a Nordic reference population

Diagnostic performances of HE4 and CA125 for the detection of ovarian cancer from patients with various gynecologic and non-gynecologic diseases

(2011) Yongjung Park et al.   CLINICAL BIOCHEMISTRY

The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?

(2011) Martina Montagnana et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting

(2011) Francis Jacob et al.   GYNECOLOGIC ONCOLOGY

HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases

(2011) Rafael Molina et al.   TUMOR BIOLOGY

Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass

(2010) Richard G. Moore et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Cancer Biomarkers: Can We Turn Recent Failures into Success?

(2010) E. P. Diamandis   JNCI-Journal of the National Cancer Institute

Ovarian tumor marker HE4 is differently expressed during the phases of the menstrual cycle in healthy young women

(2010) Emanuela Anastasi et al.   TUMOR BIOLOGY

Prognostic significance of HE4 expression in pulmonary adenocarcinoma

(2010) Shin-ichi Yamashita et al.   TUMOR BIOLOGY

Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts

(2009) K Huhtinen et al.   BRITISH JOURNAL OF CANCER

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

(2008) Richard G. Moore et al.   GYNECOLOGIC ONCOLOGY

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

(2008) Richard G. Moore et al.   GYNECOLOGIC ONCOLOGY

Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa‐foeto‐protein (AFP), neuron‐specific enolase (NSE) and CA19.9 from the NORIP study

(2008) Johan Bjerner et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass

(2007) Richard G. Moore et al.   GYNECOLOGIC ONCOLOGY